Kenvue stock rises on CEO exit as company launches strategic review and warns of lower sales
Monday, 14 July 2025 ()
Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive Officer Thibaut Mongon has stepped down. Kenvue shares were up by more than 6% during pre-market on the back of the announcement. Board director Kirk Perry has been named interim CEO while the company undergoes a […]
|
||||
|
|
||||
You Might Like |
||||
